INAB
INAB
NASDAQ · Biotechnology

In8Bio Inc

$0.82
-0.05 (-5.90%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +4,847.0% upside
Low Target $25.27
Average Target $40.58
High Target $56.74
Current Price $0.82
Current
$0.82
Target
$40.58
$25.27 $40.58 avg $56.74
Scenario Analysis
Bear Case
$25.27
2,980.6%
Low target
Base Case
$40.58
+4,847.0%
Avg target
Bull Case
$56.74
+6,817.0%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$2.73
-70.0% from high
52-Week Low
$0.80
+2.5% from low
Target vs 52W High
$40.58
+1,386.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%